However, high H19 expression was associated with a shorter relapse-free survival (RFS; HR = 2.261, 95% CI = 1.077 - 4.747, p = 0.0310) in cervical cancer patients when compared with patients with low H19 expression (Figure 1C-1D). This evidence concerns the gene H19 and cervical cancer.